The liver in times of COVID-19: What hepatologists should know
Open Access
- 18 May 2020
- journal article
- review article
- Published by Elsevier BV in Annals of Hepatology
- Vol. 19 (4), 353-358
- https://doi.org/10.1016/j.aohep.2020.05.001
Abstract
No abstract availableKeywords
Funding Information
- FONDECYT N° (1191389)
- CONICYT
This publication has 51 references indexed in Scilit:
- Viral infections in the biologic therapy eraExpert Review of Anti-infective Therapy, 2018
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesScience Translational Medicine, 2017
- Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observationInternational Journal of Rheumatic Diseases, 2017
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesJournal of Medicinal Chemistry, 2017
- Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesPharmacology Research & Perspectives, 2017
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- Liver Cirrhosis is Independently Associated With 90-Day Mortality in ARDS PatientsShock, 2016
- Coronaviruses: An Overview of Their Replication and PathogenesisPublished by Springer Science and Business Media LLC ,2015
- The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised HostsClinical Infectious Diseases, 2013
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosidesBioorganic & Medicinal Chemistry Letters, 2012